We’re proud to share that ReNewVax CEO, Neil Murray, had his article published in Pharmaphorum, addressing one of the most urgent global health challenges of our time, antimicrobial resistance (AMR).
Titled “When is the superbug message going to bite?”, the article explores the widening gap between the scientific community’s warnings and the world’s collective inaction on AMR. Drawing on insights from the recent BioInfect 2025 Conference in Liverpool, Neil Murray highlights the growing toll of drug-resistant infections, the underinvestment in novel therapies, and the urgent need for public awareness, political will, and funding innovation.
The article underscores a clear message: AMR is a slow-moving but catastrophic crisis, and meaningful change won’t happen without global alignment, sustained investment, and a visible groundswell of public pressure.
Read the full article here:
When is the superbug message going to bite? – Pharmaphorum
At ReNewVax, we remain committed to developing next-generation bacterial vaccines that directly address the burden of AMR, protecting lives and safeguarding the future of global health.